|
[1]
|
WU C L�� ZHAO S P. The status of myopathy adverse reaction induced by statins [J]�� Chin Pharm J���й�ҩѧ��־����2011 ��46 (11):872-874.
|
|
[2]
|
ZHANG X M�� WU W. Clinical application and prospect of simvastatin[J].Chin Pharm J���й�ҩѧ��־���� 2000�� 35(1):5-8.
|
|
[3]
|
MRC/BHF Heart Protection Study Collaborative Group. Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20��536 high-risk people [J]. BMC Clin Pharm�� 2009�� 9:6.
|
|
[4]
|
MATSUZAWA Y�� KITA T�� MABUCHI H�� et al. Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51��321 Japanese hypercholesterolemic patients [J]. Circ J�� 2003�� 67��4��:287-294.
|
|
[5]
|
LOW M�� RUDNICKA AR. Statin safety: A systematic review[J]. Am J Cardiol�� 2006�� 97 (8A):52-60.
|
|
[6]
|
SINHA A�� DHOLAKIA M. Myopathy with rhabdomyolysis induced by concomitant use of cyclosporine and simvastatin: A case report [J]. Arch Phys Med Rehabil�� 2008�� 89(11)��44.
|
|
[7]
|
KIERNAN T J�� ROCHFORD M�� McDERMOTT J H. Simvastatin induced rhabdomyolysis and an important clinical link with hypothyroidism [J]. Int J Cardiol�� 2007�� 119(3): 374-376.
|
|
[8]
|
HAVENS-VERKLER J�� LEWIS A M. A 73-year-old woman with rhabdomyolysis induced by simvastatin (Zocor) [J]. J Emerg Nurs�� 2004�� 30(1): 9-11.
|
|
[9]
|
STANKOVIC I�� VLAHOVIC-STIPAC A�� PUTNIKOVIC B�� et al. Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis [J]. Clin Therapeutics�� 2010�� 32: 909-914.
|
|
[10]
|
CHEN Z Q�� HONG L�� HONG W. One case about simvastatin-induced rhabdomyolysis syndrome [J]. Clin J Gen Pract���л�ȫ��ҽʦ��־���� 2008��7(8): 569-571.
|
|
[11]
|
ZHANG J D.One case of rhabdomyolysis induced by long-term application of small doses [J]. J Clin Cardiol (China)���ٴ���Ѫ�ܲ���־����2006��22(3): 189-190.
|
|
[12]
|
JIN Y Y. Pharmacological basis of the statins[J]. Clin Med J���ٴ�ҽҩ��־���� 2005�� 3(3): 3.
|
|
[13]
|
BAER A N�� WORTMANN R L. Myotoxicity associated with lipid-lowering drugs [J]. Curr Opin Rheumatol�� 2007�� 19(1): 67-73.
|
|
[14]
|
JIN T. The statins can cause rhabdomyolysis [J]. Cap Med����ҽҩ���� 2006�� 13(174): 31-34.
|
|
[15]
|
PEDERSEN T R�� TOBERT J A. Simvastatin: A review [J]. Expert Opin Pharmacother, 2004�� 5��12��:2583-2596.
|
|
[16]
|
TOMLINSON S S�� MANGIONE K K. Potential adverse effects of statins on muscle [J].Phys Ther�� 2005�� 85��5��: 459-465.
|
|
[17]
|
HO M R�� BAKER J E�� MILLER A L. Simvastatin induced rhabdomyolysis [J]. Am J Emerg Med�� 2004�� 22��3��: 234-235.
|
|
[18]
|
ROTEN L�� SCHOENENBERGER R A�� KRAHENBUHL S�� et al. Rhabdomyolysis in association with simvastatin and amiodarone [J]. Ann Pharmacother�� 2004�� 38��6��: 978-981.
|
|
[19]
|
PASTERNAK R C�� SMITH S C�� BAIRCY-MERZ C N�� et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins [J]. Stroke�� 2002�� 33(9): 2337-2341.
|
|
[20]
|
KOYA S�� CRENSHAW D�� AGARWAL A�� Rhabdomyolysis and acuter renal failure after fire ant bites [J].J Gen Inten Med�� 2007�� 22��1��: 145-147.
|
|
[21]
|
SOROKIN A V�� DUNCAN B�� PANETTA R�� et al. Rhabdomyolysis associated with pomegranate juice consumption [J]. Am J Cardiol�� 2006, 98��5��: 705-706.
|
|
[22]
|
CHANG L�� JINGANG Y�� YING W�� et al. Clinical analysis of one case of rhabdomyolysis induced by simvastatin [J].Chin J Pract Iinter Med���й�ʵ���ڿ���־���� 2008�� 28(6): 502-503.
|
|
[23]
|
RONALDSON K J�� O′SHEA J M�� BOYD I W. Risk factors for rhabdomyolysis with simvastatin and atorvastatin [J]. Drug Saf�� 2006�� 29(11): 1061-1067.
|
|
[24]
|
LI Z D�� XIAOJIN S�� DAYOU W�� et al. Rhabdomyolysis induced by drugs[J].Chin J of Clin Pharm���й��ٴ�ҩѧ��־���� 2003�� 12(1): 54-58.
|
|
[25]
|
JOANNA M Y�� CHRISTOPHER M F�� SARAH L M�� et al.Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia [J].American J Cardiology�� 2007�� 100(9): 1400-1403.
|
2012, Vol. 47 